Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$93.26 USD

93.26
953,462

-0.11 (-0.12%)

Updated Jul 29, 2024 04:00 PM ET

After-Market: $93.26 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why Alcon (ALC) is a Strong Momentum Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific

by Zacks Equity Research

DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.

Alcon (ALC) Rides on Innovation, Balanced Segmental Sales

by Zacks Equity Research

Alcon (ALC) is witnessing growth in its over-the-counter portfolio, mainly driven by favorable pricing and a sustained family of products.

Nalak Das headshot

Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H

by Nalak Das

We have narrowed our search to five Medical Instruments stocks. These are: DXCM, TMO, ISRG, ALC, HOLX.

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Aveanna Healthcare (AVAH) and Alcon (ALC) have performed compared to their sector so far this year.

Alcon (ALC) Inks Buyout Deal to Expand Its Glaucoma Portfolio

by Zacks Equity Research

Alcon (ALC) announces the closing of its deal to acquire BELKIN Vision. Per the terms of the agreement, Alcon will have access to BELKIN Vision's Direct Selective Laser Trabeculoplasty technology.

Are Options Traders Betting on a Big Move in Alcon (ALC) Stock?

by Zacks Equity Research

Investors need to pay close attention to Alcon (ALC) stock based on the movements in the options market lately.

Alcon (ALC) Achieves FDA 510(k) Clearance for Unity VCS and Unity CS

by Zacks Equity Research

Alcon (ALC) gets FDA 510(k) clearance for its Unity VCS and Unity CS. The company will start a thorough program to get real-world feedback before the systems' commercial launch in 2025.

Why Alcon (ALC) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Philips (PHG) Boosts Precision Diagnosis With AI Platform

by Zacks Equity Research

Philips (PHG) boosts its Precision Diagnosis portfolio with an AI-powered ultrasound platform, strengthening its Diagnosis & Treatment segment.

Humana (HUM) Partners With UAB to Boost Care for MA Members

by Zacks Equity Research

Humana (HUM) expands its Medicare Advantage network in Alabama through a new partnership with UAB Health System, offering greater access to enhanced healthcare services.

Compelling Reasons to Hold on to Ensign Group (ENSG) Stock

by Zacks Equity Research

Ensign Group (ENSG) remains well-poised for growth on the back of a growing revenue base, an expanding healthcare portfolio and solid cash reserves.

Philips (PHG) Boosts Medical Imaging Footprint With New Move

by Zacks Equity Research

Philips (PHG) expands its international footprint with the wide availability of VeriSight Pro 3D to several Hong Kong hospitals, strengthening its Diagnosis & Treatment segment.

Reasons to Include Alcon (ALC) in Your Portfolio Right Now

by Zacks Equity Research

New product launches and strong solvency bode well for Alcon (ALC).

Philips (PHG) Strengthens Patient Monitoring Services in Spain

by Zacks Equity Research

Philips (PHG) announces the wide availability of its ambulatory cardiac monitoring service in Spain, boosting its patient monitoring solutions portfolio.

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.

Do Options Traders Know Something About Alcon (ALC) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Alcon (ALC) stock based on the movements in the options market lately.

Nalak Das headshot

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio

by Nalak Das

We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These stocks are: ALC, RXST, HOLX, VCYT, MASI.

Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now

by Zacks Equity Research

DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.

Urmimala Biswas headshot

3 Solid Buys From MedTech Following 2024 Guidance Raise

by Urmimala Biswas

Guidance hikes by BSX, ALGN and ALC for 2024 make them attractive investment bets.

Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand

by Zacks Equity Research

Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.

Here's Why You Should Retain Centene (CNC) Stock for Now

by Zacks Equity Research

Centene (CNC) remains well-poised for growth on the back of sound growth in membership, divestitures and a growing cash balance.

Compared to Estimates, Alcon (ALC) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Shaun Pruitt headshot

2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach

by Shaun Pruitt

Among the medical sector, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.

Why Alcon (ALC) Might Surprise This Earnings Season

by Zacks Equity Research

Alcon (ALC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.